Mobile ECG Devices Market Report Scope & Overview:

The Mobile ECG Devices Market was valued at USD 3.21 Billion in 2025 and is expected to reach USD 8.07 Billion by 2035, growing at a CAGR of 9.66% from 2026 to 2035.

Mobile ECGs are employed in the detection and monitoring of cardiac activities and the occurrence of cardiac arrhythmia in individuals owing to the increasing number of cardiac diseases amongst the population and increased awareness about early detection of such conditions. For example, atrial fibrillation, which is one of the prevalent forms of cardiac arrhythmias, affects about forty million people worldwide, including about six million people from the US alone. Some of the top companies involved in the development of mobile ECG devices focus on the creation of better technologies, such as the artificial intelligence-based hand-held system.

AliveCor, a United States-based medical technology company, introduced an AI-powered handheld system in July 2025 designed to leverage artificial intelligence for analyzing cardiac data in real time and delivering rapid, reliable diagnostic insights to patients and clinicians.

Market Size and Forecast

• Market Size in 2026E: USD 3.52 Billion
• Market Size by 2035: USD 8.07 Billion
• CAGR: 9.66% from 2026 to 2035
• Fastest Growing Region: Asia Pacific
• Largest Region: North America

To Get more information Mobile ECG Devices Market - Request Free Sample Report

Mobile ECG Devices Market Trends

• The market is evolving from basic heart rate and rhythm tracking toward advanced cardiovascular intelligence capabilities.
• Expanding mobile ECG data applications beyond atrial fibrillation detection now include predictive analytics for heart failure.
• Cardiologist-reviewed ECG diagnostics delivered to patients in homes and underserved communities continue enhancing accessibility.
• Growing presence of med-tech startups and healthcare organization collaborations continue enhancing awareness and adoption.
• Expansion of telehealth services and improved affordability of portable medical devices continue supporting sustained adoption.

The United States Mobile ECG Devices Market Outlook

The United States Mobile ECG Devices Market was valued at USD 1.27 Billion in 2025 and is expected to reach USD 3.29 Billion by 2035, growing at a CAGR of 10.00% from 2026 to 2035.

The United States continues to see increasing demand for ambulatory cardiac monitoring, driven by a high prevalence of arrhythmia and robust initiatives by companies to expand product availability through collaborations and regulatory approvals. Heart disease continues to be the number-one cause of death in the country, responsible for approximately seven hundred two thousand eight hundred eighty deaths annually, or roughly one in five deaths, a statistic that has triggered a strong government response including increased capital for digital health infrastructure and expanded Medicare coverage for remote patient monitoring.

HeartBeam received United States Food and Drug Administration 510(k) certification in January 2025 for its portable, cable-free ambulatory ECG device, transforming at-home cardiac monitoring capability available to American patients and healthcare providers.

Mobile ECG Devices Market Segmentation Analysis

• By Device Type, the handheld segment held approximately 41.20% share in the mobile ECG devices market in 2025, while the patch segment is the fastest growing.
• By Connectivity, the bluetooth segment held the largest share in the mobile ECG devices market in 2025, while the wifi cellular segment is the fastest growing.
• By Technology, the diagnostics ECG Systems segment held approximately 58.40% share in the mobile ECG devices market in 2025, while the Monitoring ECG Systems segment is the fastest growing, with a CAGR of approximately 7.95%.
• By Application, the arrhythmia detection segment held the largest share in the mobile ECG devices market in 2025, while the predictive cardiovascular analytics segment is the fastest growing.
• By End User, the hospitals and diagnostic centers segment held approximately 48.70% share in the mobile ECG devices market in 2025, while the personal users segment is the fastest growing.

By Device Type, handheld segment dominates the mobile ECG devices market, while patch segment grows fastest

The Handheld segment held approximately 41.20% of total market revenue in 2025, primarily due to its balanced combination of portability and functionality that continues appealing to both clinical and personal users. That balance of convenience and diagnostic capability continues to keep handheld devices firmly at the top of the broader device type segmentation across the majority of mobile ECG deployments worldwide.

The Patch segment is projected to grow at the fastest CAGR during the forecast period, supported by increasing product introductions catering to patient needs and rising preference for convenient, wearable cardiac monitoring solutions that do not require active user operation. Patch-based devices, which affix to the chest and transmit ECG readings via Bluetooth without requiring leads or wires, continue benefiting from robust product launches by key players, pushing this device type category's growth rate ahead of the broader device type segmentation.

By Connectivity, bluetooth segment dominates the mobile ECG devices market, while WiFi grows fastest

The Bluetooth segment held the largest share of the connectivity segmentation in 2025, reflecting its established role as the primary wireless protocol enabling patch and handheld devices to transmit ECG readings directly to smartphones without requiring leads or wires. That established connectivity standard continues to keep Bluetooth firmly at the top of the broader connectivity segmentation across the majority of current mobile ECG deployments worldwide.

The WiFi Cellular segment is projected to grow at the fastest CAGR during the forecast period, supported by rising demand for continuous, real-time remote monitoring capability that does not depend on proximity to a paired smartphone. Continued expansion of cellular-enabled ambulatory monitoring continues to push this connectivity segment's growth rate ahead of the broader connectivity segmentation.

By Application, arrhythmia detection segment dominates the mobile ECG devices market, while predictive cardiovascular analytics grows fastest

The Arrhythmia Detection segment held the largest share of the application segmentation in 2025, anchored by atrial fibrillation's status as one of the most common types of cardiac arrhythmia, affecting approximately forty million people globally. That substantial and growing patient population continues to keep arrhythmia detection firmly at the center of overall mobile ECG devices demand across nearly every major regional market worldwide.

The Predictive Cardiovascular Analytics segment is projected to grow at the fastest CAGR during the forecast period, as stakeholders increasingly pursue a preventive cardiovascular intelligence strategic framework that expands mobile ECG data applications beyond atrial fibrillation detection to include predictive analytics for heart failure and silent myocardial ischemia. Rising demand for this expanded diagnostic capability continues to push this application segment's growth rate ahead of the broader application segmentation.

By End User, hospitals and diagnostic centers segment dominates the mobile ECG devices market, while personal users grows fastest

The Hospitals and Diagnostic Centers segment held approximately 48.70% of total market revenue in 2025, anchored by the comprehensive clinical infrastructure and specialist availability required to interpret and act upon complex cardiac monitoring data. That established clinical infrastructure continues to keep hospitals and diagnostic centers firmly at the top of the broader end user segmentation.

The Personal Users segment is projected to grow at the fastest CAGR during the forecast period, supported by expanding telehealth services and improved affordability of portable medical devices that continue making self-monitoring increasingly accessible. Rising consumer adoption of at-home cardiac monitoring continues to push this end user segment's growth rate ahead of the broader end user segmentation.

Regional Analysis

North America Mobile ECG Devices Market Insights

North America held the largest share of the global mobile ECG devices market in 2025, at approximately 44.78%, driven by the rising prevalence of cardiac arrhythmia, growing awareness regarding early diagnosis, and robust product launches by key players. Increasing demand for ambulatory cardiac monitoring, driven by a high prevalence of arrhythmia, continued reinforcing this leadership position throughout the year.

The U.S. had a share of almost 85.00% in the regional revenue, due to presence of prominent mobile ECG device makers and a well-developed healthcare reimbursement system in the country. The share held by Canada was lower but it grew consistently, owing to increased adoption of cardiac monitoring solutions in the country, which helped North America dominate all other regions.

Get Customized Report as per Your Business Requirement - Enquiry Now

Europe Mobile ECG Devices Market Insights

Europe held a substantial share of the global mobile ECG devices market in 2025, supported by the growing presence of med-tech startups and collaborations with healthcare organizations that continue enhancing awareness and adoption of mobile ECG devices for early cardiac disorder detection. Germany accounted for roughly 27.30% of regional revenue, supported by its concentration of medical device manufacturers and comprehensive healthcare infrastructure.

France and the United Kingdom followed a broadly similar trajectory, as continued investment in digital health infrastructure extended mobile ECG devices demand across the continent's largest healthcare markets. Continued regulatory support for remote cardiac monitoring is expected to keep supporting steady European demand through the remainder of the forecast period.

Asia Pacific Mobile ECG Devices Market Insights

Asia Pacific was the fastest-growing region in the global mobile ECG devices market, supported by rising cardiovascular disease prevalence, expanding healthcare infrastructure investment, and growing telehealth adoption across the region's largest and most populous economies. Rising healthcare digitization continued driving regional demand at a pace considerably faster than more mature Western markets.

China accounted for roughly 36.50% of regional revenue, supported by expanding domestic healthcare infrastructure and growing cardiac monitoring technology adoption. Japan and South Korea contributed significant additional regional demand through their own advanced healthcare technology adoption, reinforcing Asia Pacific's position as the clear growth leader in this market.

MEA & Latin America Mobile ECG Devices Market Insights

The Middle East and Africa region recorded steady growth in mobile ECG devices adoption in 2025, driven by expanding healthcare infrastructure investment and growing government support for cardiac disease screening programs across the Gulf states in particular. The UAE accounted for roughly 26.40% of regional revenue, supported by national healthcare modernization strategies and rising demand for advanced cardiac monitoring technology.

Latin America expanded at a comparable pace, led by Brazil at roughly 37.20% of regional revenue, where growing healthcare infrastructure investment continued to support category growth. Mexico and Argentina followed a similar trajectory as regional cardiac monitoring technology adoption expanded further through the remainder of the forecast period.

Growth Drivers: Rising Arrhythmia Prevalence and Remote Patient Monitoring Expansion

The rising prevalence of cardiac disorders among the population and increasing awareness regarding early diagnosis of the disorder and possible treatment options continue to be the central force behind mobile ECG devices market growth. Increased focus on advanced monitoring of cardiovascular health, coupled with general acceptance of digital health systems, continues driving remarkable growth throughout the forecast period.

Expanding Medicare coverage for remote patient monitoring, alongside increasing capital for digital health infrastructure from government health agencies, continues directly encouraging acceptance of home-based ECG monitoring systems. Expansion of telehealth services and improved affordability of portable medical devices continue reinforcing structural demand growth across the broader mobile ECG devices market.

Restraints: Device Accuracy Limitations and High Technology Development Costs

The limited accuracy of certain mobile ECG devices relative to full clinical-grade diagnostic equipment continues restricting their use to screening and preliminary detection rather than definitive diagnosis in more complex cases. That accuracy limitation continues requiring confirmatory clinical-grade testing for patients whose mobile ECG readings indicate potential abnormalities.

The high development costs associated with technologically advanced mobile ECG devices, particularly those incorporating AI-powered diagnostic capability, continue restricting the pace at which smaller manufacturers can compete against established medical technology companies. That cost barrier continues concentrating the most advanced mobile ECG technology development among well-resourced industry participants.

Opportunities: Predictive Analytics Expansion and Underserved Community Access

Continued expansion of mobile ECG data applications beyond atrial fibrillation detection into predictive analytics for heart failure and silent myocardial ischemia presents substantial opportunity for manufacturers positioned to serve this evolving diagnostic capability. Manufacturers capable of delivering genuinely predictive cardiovascular intelligence stand to capture a growing share of demand as this technology continues maturing.

Delivering high-quality, cardiologist-reviewed ECG diagnostics to patients in homes and underserved communities presents a further significant growth avenue, as this approach continues enhancing accessibility for populations that have historically lacked convenient access to cardiac specialists. Manufacturers capable of supporting this expanded access model stand to capture meaningful new revenue streams through 2035.

Recent Developments:

• 2025: Peerbridge Health announced the launch of Cor MDx in March, a next-generation IoT ECG wearable featuring real-time multi-lead ECG monitoring capability for both clinical and home-based use.
• 2025: iRhythm Technologies continued expanding its ambulatory cardiac monitoring platform, strengthening its position serving hospitals and cardiology practices requiring extended-wear ECG monitoring solutions.
• 2025: Nihon Kohden continued advancing its mobile ECG device portfolio, targeting healthcare providers seeking integrated cardiac monitoring solutions across hospital and ambulatory care settings.

Mobile ECG Devices Market key players are:

• AliveCor, Inc.
• Beurer UK Ltd.
• Borsam Biomedical Instrument
• GE HealthCare
• Medtronic plc
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• Emay
• Dr Trust
• Omron Corporation
• Nihon Kohden Corporation
• InfoBionic
• BHA Medical
• Lepu Medical Technology (Beijing) Co., Ltd.
• HeartBeam, Inc.
• Peerbridge Health
• Withings
• Fitbit LLC
• Apple Inc.
• Biotricity Inc.

Mobile ECG Devices Market Report Scope :